These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36576463)

  • 1. Urinary epidermal growth factor and monocyte chemotactic protein-1 as biomarkers of renal injury in patients with obstructed nephropathy.
    El-Dydamony EM; Abdelaal MA; Kasim SA; Ameen DR; El-Fattah DAA
    Arch Ital Urol Androl; 2022 Dec; 94(4):443-446. PubMed ID: 36576463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
    BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of urinary monocyte chemotactic protein 1 and epidermal growth factor and their correlations with clinicopathology in idiopathic membranous nephropathy patients].
    Zheng S; Zhao ZH; Liu ZJ; Wang DH; Liu DW; Liu ZS
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(16):1230-1234. PubMed ID: 32344494
    [No Abstract]   [Full Text] [Related]  

  • 5. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G; Gesualdo L; Bartoli F; Ranieri E; Monno R; Leggio A; Paradies G; Caldarulo E; Infante B; Schena FP
    Kidney Int; 2000 Jul; 58(1):182-92. PubMed ID: 10886563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Study on Several Urinary Biomarkers as Indicators of Renal Damage in Children with CAKUT.
    Bartoli F; Pastore V; Calè I; Aceto G; Campanella V; Lasalandra C; Magaldi S; Niglio F; Basile A; Cocomazzi R
    Eur J Pediatr Surg; 2019 Apr; 29(2):215-222. PubMed ID: 29727865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy.
    Chertin B; Farkas A; Puri P
    Eur Urol; 2003 Jul; 44(1):144-9. PubMed ID: 12814691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
    Madsen MG; Nørregaard R; Palmfeldt J; Olsen LH; Frøkiær J; Jørgensen TM
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):838-45. PubMed ID: 23228281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of EGF and MCP-1 in children with vesicoureteral reflux.
    Pastore V; Bartoli F
    Int Braz J Urol; 2017; 43(3):549-555. PubMed ID: 28191787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
    Torres DD; Rossini M; Manno C; Mattace-Raso F; D'Altri C; Ranieri E; Pontrelli P; Grandaliano G; Gesualdo L; Schena FP
    Kidney Int; 2008 Feb; 73(3):327-33. PubMed ID: 17943082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
    Chanrat E; Worawichawong S; Radinahamed P; Sathirapongsasuti N; Nongnuch A; Assanatham M; Udomsubpayakul U; Kitiyakara C
    Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
    Idasiak-Piechocka I; Miedziaszczyk M; Woźniak A; Pawliczak E; Kaczmarek E; Oko A
    Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1267-C1275. PubMed ID: 37721004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis.
    Worawichawong S; Worawichawong S; Radinahamed P; Muntham D; Sathirapongsasuti N; Nongnuch A; Assanatham M; Kitiyakara C
    Kidney Blood Press Res; 2016; 41(6):997-1007. PubMed ID: 27988512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
    Yu L; Zhou L; Li Q; Li S; Luo X; Zhang C; Wu B; Brooks JD; Sun H
    J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
    Li Z; Zhao Z; Liu X; Su Z; Shang X; Wen J
    Pediatr Nephrol; 2012 Dec; 27(12):2251-9. PubMed ID: 22773267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease.
    Rocchetti MT; Pesce F; Matino S; Piscopo G; di Bari I; Trepiccione F; Capolongo G; Perniola MA; Song X; Khowaja S; Haghighi A; Peters D; Paolicelli S; Pontrelli P; Netti GS; Ranieri E; Capasso G; Moschetta M; Pei Y; Gesualdo L;
    J Nephrol; 2023 May; 36(4):987-997. PubMed ID: 36342644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
    Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease.
    Cortvrindt C; Speeckaert R; Delanghe JR; Speeckaert MM
    Am J Nephrol; 2022; 53(5):372-387. PubMed ID: 35537382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    Ngamjanyaporn P; Worawichawong S; Pisitkun P; Khiewngam K; Kantachuvesiri S; Nongnuch A; Assanatham M; Sathirapongsasuti N; Kitiyakara C
    PLoS One; 2022; 17(3):e0263778. PubMed ID: 35271583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
    Menez S; Wen Y; Xu L; Moledina DG; Thiessen-Philbrook H; Hu D; Obeid W; Bhatraju PK; Ikizler TA; Siew ED; Chinchilli VM; Garg AX; Go AS; Liu KD; Kaufman JS; Kimmel PL; Himmelfarb J; Coca SG; Cantley LG; Parikh CR
    Kidney Int; 2023 Dec; 104(6):1194-1205. PubMed ID: 37652206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.